Results 141 to 150 of about 78,942 (265)

Diagnostic challenges of spinal gout: patient series. [PDF]

J Neurosurg Case Lessons
Zhou Y, Wu H, Huang Y, Man Y, He M.
europepmc   +1 more source

Comorbidities and Healthcare Utilization in 4197 Patients With Prurigo Nodularis in Israel: A Cross‐Sectional Population‐Based Analysis

International Journal of Dermatology, EarlyView.
ABSTRACT Background Prurigo nodularis patients face a significant burden of comorbidities, necessitating a comprehensive approach to care. We aimed to explore the association between prurigo nodularis, its comorbid conditions, and healthcare usage patterns.
Yuliya Valdman‐Grinshpoun, Andrea Zaga, Arnon Dov Cohen, Yochai Schonmann, Tali Czarnowicki   +4 more
wiley   +1 more source

Gouty stone of the left bulbar conjunctiva: Report of a rare case

Asian Journal of Surgery
Benwei Cheng, Huixiang Chen, Wenhao Zhu, Yu Lei   +3 more
doaj   +1 more source

Epigenetic programming reshapes innate immune memory: decoding the molecular imprint of gouty inflammation. [PDF]

Front Pharmacol
Su W, Lu Y, Luo Z, Xiong H.
europepmc   +1 more source

Relationship between the Chinese visceral adiposity index and gout in individuals with type 2 diabetes mellitus: a cross-sectional population-based study. [PDF]

Front Nutr
Cai N, Chen M, Feng P, Wang Y, Zhu X, Zheng Q.   +5 more
europepmc   +1 more source

Analysis of the results of treatment of patients with deformities of the feet with gout

, 2020
Yu.V. Larcev, D.A. Rasputin
openalex   +1 more source

Use of Drugs With Actionable Pharmacogenetic Biomarkers and Possible Prescribing Changes Among Older People

Journal of the American Geriatrics Society, EarlyView.
This graphical abstract illustrates the annual prevalence of exposure to CPIC Level A drugs among older adults, categorized by type of pharmacogenetic recommendation. Data are presented per 1000 older individuals (A) and per 1000 prescriptions (B).
Zinan Zhao, Yuxuan Zhao, Xiaowen Hu, Xue Wang, Gengchen Wang, Xinyi Zhang, Wenliang Dong, Luwen Shi, Xiaodong Guan, Christine Y. Lu, Pengfei Jin, Xiaoyan Nie   +11 more
wiley   +1 more source

Hepatic Safety of Febuxostat and Allopurinol in Gout Patients: An Updated Systematic Review and Meta-Analysis of Randomized Controlled Trials. [PDF]

Ther Clin Risk Manag
Dewi C, Puspita F, Insani WN, Sinuraya RK, Puspitasari IM, Zakiyah N.   +5 more
europepmc   +1 more source

GLP‐1 Receptor Agonist Therapy and Cardiorenal Outcomes in Patients ≥ 80 Years Old With Type 2 Diabetes

Journal of the American Geriatrics Society, EarlyView.
Effect of glucagon‐like peptide‐1 receptor agonist therapy on cardiorenal outcomes in patients aged ≥ 80 years with Type 2 diabetes. ABSTRACT Background Glucagon‐like peptide‐1 receptor agonists (GLP‐1 RAs) have demonstrated potential in improving glycemic control and reducing adverse outcomes in patients with Type 2 diabetes mellitus (T2DM); however ...
Jui‐Cheng Chen, Yu‐Wei Fang, Ya‐Fang Liu, Mon‐Ting Chen, Ming‐Hsien Tsai   +4 more
wiley   +1 more source

Advancing Gouty Arthritis Research: The Clinical Value of Complete Blood Cell Count Ratios and Immune-Inflammatory Interactions. [PDF]

J Inflamm Res
Gao L, Liu C, Ye G, Gao Y, Wang H.
europepmc   +1 more source